Skip to content
AnalystLens

3M CO 8-K Report, Financial Results (Oct 22, 2024)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed October 22, 2024
Period End
October 22, 2024
Security
MMM
In the record · 2016–202610-K1110-Q338-K187

MMM filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 187 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Nov ’18Nov ’18
  2. Material agreement8-K · Nov ’20Nov ’20
  3. Impairment8-K · Dec ’22Dec ’22
  4. Material agreement8-K · Aug ’26Aug ’26

01—Abstract

Summary

Summary of the 8-K filed October 22, 2024. Cited figures are marked; the original filing is the authoritative source.

3M reported third-quarter 2024 results on October 22, 2024 that were mixed on the top line but strong on earnings.

Reported net sales were $6.3 billiona, up 0.4% year-on-year, while adjusted sales were $6.1 billion, up 1.5%, with adjusted organic growth of 1.0%. GAAP EPS from continuing operations was $2.48, up 154%, driven largely by a $581 million non-cash gain on the change in value of 3M's retained Solventum stake. Adjusted EPS from continuing operations was $1.98, up 18% year-on-year, and adjusted operating margin expanded 1.4 percentage points to 23.0%.

Reported GAAP organic sales were slightly negative at (0.1)%, reflecting a 100 basis point headwind from portfolio initiatives and small-country exits. Cash generation was the main concern in the quarter. Operating cash flow was $(1.8) billion, driven by $3.6 billionb in net after-tax payments for significant litigation, primarily Public Water Systems and Combat Arms Earplugs settlements.

Adjusted free cash flow was still a positive $1.5 billionc. For the nine months, operating cash flow was roughly breakeven at $1 million, versus $4.7 billion a year earlier, while net debt fell to $5.9 billion from $10.2 billion at year-end 2023, helped by the Solventum separation and cash on hand. Total debt stood at $13.2 billion against $7.3 billion of cash and marketable securities.

Management raised the low end of its full-year 2024 adjusted EPS guidance to $7.20d-$7.30 from $7.00-$7.30. Adjusted organic sales growth is now expected at about 1%, versus a prior range of flat to +2%, and adjusted total sales growth at about 1%. Investors should weigh the improved earnings outlook against continuing litigation cash outflows and the company's ongoing PFAS exposure and planned exit from PFAS manufacturing by the end of 2025.

02—Key points

Key Highlights

  1. Q3 2024 adjusted EPS of $1.98, up 18% year-on-year, versus GAAP EPS from continuing operations of $2.48, up 154%, which includes a $581 million non-cash gain tied to the Solventum ownership stake.
  2. Adjusted operating income margin rose to 23.0% from 21.6% a year earlier, an increase of 1.4 percentage points.
  3. Reported organic sales were down 0.1% and adjusted organic sales were up 1.0%, with a 100 bp headwind from portfolio initiatives and exits from small countries.
  4. Operating cash flow was $(1.8) billion in Q3, driven by $3.6 billion of after-tax litigation payments, while adjusted free cash flow was $1.5 billion.
  5. Full-year 2024 adjusted EPS guidance narrowed upward to $7.20-$7.30 from $7.00-$7.30, while adjusted organic sales growth guidance was lowered to about 1% from flat to +2%.
  6. Net debt fell to $5.9 billion at September 30, 2024 from $10.2 billion at December 31, 2023, following the Solventum separation.
  7. 3M returned $1.1 billion to shareholders in Q3 through dividends and share repurchases, while continuing to face significant PFAS and Combat Arms Earplugs litigation payments.

03—Questions

Frequently Asked Questions

  1. Why did GAAP EPS jump so much compared with adjusted EPS?

    GAAP EPS of $2.48 includes a $581 million non-cash gain from the change in value of 3M's retained Solventum shares, which added about $1.05 per share. Adjusted EPS strips out this gain and other special items, including $0.51 per share of significant litigation costs, leaving adjusted EPS of $1.98.

  2. Why was operating cash flow negative in the third quarter?

    Operating cash flow of $(1.8) billion was driven mainly by about $3.6 billion in net after-tax payments for significant litigation, primarily the Public Water Systems PFAS settlement and Combat Arms Earplugs settlement. Excluding these special items, adjusted operating cash flow was $1.8 billion.

  3. Did 3M raise its full-year guidance?

    Partly. The low end of adjusted EPS guidance was raised to $7.20 from $7.00, so the range is now $7.20-$7.30. However, adjusted organic sales growth guidance was lowered to about 1% from a range of flat to +2%, and adjusted total sales growth is now about 1% versus a prior range of (0.25)% to +1.75%.

  4. How much debt does 3M have and how has its balance sheet changed?

    Total debt was $13.2 billion at September 30, 2024, down from $16.0 billion at year-end 2023. Cash and marketable securities were $7.3 billion, resulting in net debt of $5.9 billion, compared with $10.2 billion at December 31, 2023.

  5. What are the main risks highlighted in the filing?

    The filing highlights ongoing PFAS-related liabilities, including the class-action settlement with US public water suppliers and the planned exit from PFAS manufacturing by the end of 2025. It also cites Combat Arms Earplugs litigation, the Solventum separation's effects, pension obligations, and foreign currency and macroeconomic conditions.

04—Continue

← View all 8-K filings